These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 11451697

  • 1. Once-daily oral gatifloxacin versus oral levofloxacin in treatment of uncomplicated skin and soft tissue infections: double-blind, multicenter, randomized study.
    Tarshis GA, Miskin BM, Jones TM, Champlin J, Wingert KJ, Breen JD, Brown MJ.
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2358-62. PubMed ID: 11451697
    [Abstract] [Full Text] [Related]

  • 2. A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections.
    Nicodemo AC, Robledo JA, Jasovich A, Neto W.
    Int J Clin Pract; 1998 Mar; 52(2):69-74. PubMed ID: 9624783
    [Abstract] [Full Text] [Related]

  • 3. Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections.
    Naber KG, Allin DM, Clarysse L, Haworth DA, James IG, Raini C, Schneider H, Wall A, Weitz P, Hopkins G, Ankel-Fuchs D.
    Int J Antimicrob Agents; 2004 Jun; 23(6):596-605. PubMed ID: 15194131
    [Abstract] [Full Text] [Related]

  • 4. Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study.
    Henry DC, Kapral D, Busman TA, Paris MM.
    Clin Ther; 2004 Dec; 26(12):2026-33. PubMed ID: 15823766
    [Abstract] [Full Text] [Related]

  • 5. A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
    Schwab IR, Friedlaender M, McCulley J, Lichtenstein SJ, Moran CT, Levofloxacin Bacterial Conjunctivitis Active Control Study Group.
    Ophthalmology; 2003 Mar; 110(3):457-65. PubMed ID: 12623805
    [Abstract] [Full Text] [Related]

  • 6. Fleroxacin 400 mg once daily versus ofloxacin 400 mg twice daily in skin and soft tissue infections.
    Drehobl M, Koenig L, Barker M, St Clair P, Maladorno D.
    Chemotherapy; 1997 Mar; 43(5):378-84. PubMed ID: 9309373
    [Abstract] [Full Text] [Related]

  • 7. A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis.
    Adelglass J, Jones TM, Ruoff G, Kahn JB, Wiesinger BA, Rielly-Gauvin K, Siu CO.
    Pharmacotherapy; 1998 Mar; 18(6):1255-63. PubMed ID: 9855324
    [Abstract] [Full Text] [Related]

  • 8. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
    Schwartz RH.
    Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576
    [Abstract] [Full Text] [Related]

  • 9. Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infections.
    Lipsky BA, Miller B, Schwartz R, Henry DC, Nolan T, McCabe A, Magner DJ, Talbot GH.
    Clin Ther; 1999 Apr; 21(4):675-90. PubMed ID: 10363733
    [Abstract] [Full Text] [Related]

  • 10. Single-dose gatifloxacin compared with ofloxacin for the treatment of uncomplicated gonorrhea: a randomized, double-blind, multicenter trial.
    Stoner BP, Douglas JM, Martin DH, Hook EW, Leone P, McCormack WM, Mroczkowski TF, Jones R, Yang J, Baumgartner T.
    Sex Transm Dis; 2001 Mar; 28(3):136-42. PubMed ID: 11289194
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria.
    Stryjewski ME, O'Riordan WD, Lau WK, Pien FD, Dunbar LM, Vallee M, Fowler VG, Chu VH, Spencer E, Barriere SL, Kitt MM, Cabell CH, Corey GR, FAST Investigator Group.
    Clin Infect Dis; 2005 Jun 01; 40(11):1601-7. PubMed ID: 15889357
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.